نتائج البحث - "Cinacalcet"

1

Report

A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

المصدر: Phase II Study of ASP7991 -A Double-blind, Cinacalcet Hydrochloride-controlled, Dose-ascending Study in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

View record in ClinicalTrials.gov

2

Report

Novel Combination Therapy for Osteoporosis in Men (Osteo-Men)

المؤلفون: University of California, San Francisco

المصدر: Novel Combination Therapy for Osteoporosis in Men

View record in ClinicalTrials.gov

3

Report

Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?

المؤلفون: Karolinska Institutet

المساهمون: Inga-Lena Nilsson, M.D., Ph.D; Assoc.prof.

المصدر: Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Koman A, Ohlsson S, Branstrom R, Pernow Y, Branstrom R, Nilsson IL. Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy. Br J Surg. 2019 Dec;106(13):1810-1818. doi: 10.1002/bjs.11319. Epub 2019 Oct 9.

View record in ClinicalTrials.gov

4

Report

The Trial of SHR6508 in Secondary Hyperparathyroidism

المصدر: A Multicenter, Randomised, Double-blind, Double-dummy Study to Assess the Efficacy and Safety of SHR6508 in Hemodialysis Subjects With Secondary Hyperparathyroidism

View record in ClinicalTrials.gov

5

Report

DePTH: De-emphasize PTH

المؤلفون: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

المساهمون: Simon Hsu, MD, MS, Assistant Professor

المصدر: DePTH: De-emphasize Parathyroid Hormone

View record in ClinicalTrials.gov

6

Report

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT (ACTIVE)

المصدر: A Multi-center Study Evaluating Efficacy and Safety of Cinacalcet Hydrochloride(HCL) in Calcium, Phosphorus and Intact Parathyroid Hormone(iPTH) Serum Levels in Chinese Chronic Kidney Disease(CKD) Hemodialysis(HD) Patients With Mild, Moderate and Severe Secondary Hyperparathyroidism(SHPT)

View record in ClinicalTrials.gov

7

Report

Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular Hemodialysis

المساهمون: Sara Mabrouk Elghoul, Principal Investigator, Clinical Lecturer of Pediatric Nephrology

المصدر: Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular Hemodialysis

View record in ClinicalTrials.gov

8

Academic Journal

Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report.

المؤلفون: Faiq, Samya, Lavelle, Kristen, Hu, Tina, Shoback, Dolores, Ku, Gregory

المصدر: BMC endocrine disorders. 23(1)

مصطلحات موضوعية: Humans, Hypercalcemia, Calcium, Parathyroid Hormone-Related Protein, Parathyroid Hormone, Middle Aged, Male, Cinacalcet, Zoledronic Acid, Bisphosphonate, Case report, Osteonecrosis, PTHrP, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Clinical Sciences, Endocrinology & Metabolism

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/9bv6v41p
https://escholarship.org/content/qt9bv6v41p/qt9bv6v41p.pdf

View record in eScholarship

9

Academic Journal

Parathyroidectomy and Cinacalcet Use in Medicare-Insured Kidney Transplant Recipients.

المؤلفون: Liu, Sai, Montez-Rath, Maria, Chertow, Glenn, Lenihan, Colin, Wang, Aileen

المصدر: American Journal of Kidney Diseases. 81(3)

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/1p12k6m0

View record in eScholarship

10

Report

A Study of SHR6508 in Secondary Hyperparathyroidism

المصدر: An Open-label, Randomized, Active-Controlled Dose Titration Study to Assess the Efficacy and Safety of SHR6508 in Hemodialysis Subjects With Secondary Hyperparathyroidism

View record in ClinicalTrials.gov

11

Academic Journal

Hereditary vitamin D resistant rickets (HVDRR) case series: phenotype, genotype, conventional treatment, and adjunctive cinacalcet therapy

المؤلفون: Noman Ahmad, Sundus A. Ansari, Nabil A. Aleysae, Emily L.G. Heaphy, Mrouge M. Sobaihi, Balgees A. Alghamdi, Ali S. Alzahrani

المصدر: Pediatric Endocrinology, Diabetes and Metabolism, Vol 30, Iss 2, Pp 74-80 (2024)

مصطلحات موضوعية: vitamin d, rickets, calcium, cinacalcet., Pediatrics, RJ1-570, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

Relation: https://www.termedia.pl/Hereditary-vitamin-D-resistant-rickets-HVDRR-case-series-phenotype-r-ngenotype-conventional-treatment-and-adjunctive-cinacalcet-therapy,138,54087,1,1.html; https://doaj.org/toc/2081-237X; https://doaj.org/toc/2083-8441

URL الوصول: https://doaj.org/article/2135671fd2bc4986932a8cd5e52fd0b7

View record in DOAJ

Full Text Finder

12

Academic Journal

Development and Characterization of a Novel Spray-Dried Powder for Inhalation of Cinacalcet HCl Nanoparticles

المؤلفون: Katayoon Mireskandari, Mostafa Rostamnezhad, Majid Darabi, Mohammadreza Rouini, Alireza Vatanara

المصدر: Pharmaceutical Sciences, Vol 30, Iss 2, Pp 229-243 (2024)

مصطلحات موضوعية: cinacalcet hcl, dissolution profile, dry powder inhalation, nanosuspension, solubility, sonoprecipitation, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: https://ps.tbzmed.ac.ir/PDF/ps-30-229.pdf; https://doaj.org/toc/2383-2886

URL الوصول: https://doaj.org/article/6e8fbc392dce4a0a95690b42df0d844c

View record in DOAJ

13

Academic Journal

Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients

المؤلفون: Nobuo Nagano, Takayuki Ishikawa, Masashi Yamaguchi, Yuji Katsuragi, Masaaki Miya, Noriko Tamei, Shigeaki Muto, Takaaki Tsutsui, Tetsuya Ogawa, Kyoko Ito

المصدر: Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-7 (2024)

مصطلحات موضوعية: Secondary hyperparathyroidism, Evocalcet, Cinacalcet hydrochloride, Evocalcet dosage, Serum parathyroid hormone levels, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2059-1381

URL الوصول: https://doaj.org/article/4241806a714041298f3194bb1fc8cb9c

View record in DOAJ

14

Report

Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism

المساهمون: Anand Vaidya, Assistant Professor of Medicine, Harvard Medical School

المصدر: Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism

View record in ClinicalTrials.gov

15

Academic Journal

Comparative efficacy of sodium thiosulfate, bisphosphonates, and cinacalcet for the treatment of vascular calcification in patients with haemodialysis: a systematic review and network meta-analysis

المؤلفون: Lei He, Yuzhe Li, Jingjing Jin, Meijuan Cheng, Yaling Bai, Jinsheng Xu

المصدر: BMC Nephrology, Vol 25, Iss 1, Pp 1-15 (2024)

مصطلحات موضوعية: Vascular calcification, Haemodialysis, Sodium thiosulfate, Bisphosphonates, Cinacalcet, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2369

URL الوصول: https://doaj.org/article/b779f8bdb05c49c68583057fdebd248d

View record in DOAJ

Full Text Finder

16

Report

Renal Osteodystrophy: An Individual Management Approach

المؤلفون: Wright State University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

المساهمون: Hartmut Malluche, MD, Principal Investigator

المصدر: Renal Osteodystrophy: A Fresh Approach
Hara T, Hijikata Y, Matsubara Y, Watanabe N. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D. Cochrane Database Syst Rev. 2021 Jul 7;7(7):CD013424. doi: 10.1002/14651858.CD013424.pub2.

View record in ClinicalTrials.gov

17

Report

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events (EVOLVE)

المصدر: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
Chertow GM, Correa-Rotter R, Block GA, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Wheeler DC, Parfrey PS. Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant. 2012 Jul;27(7):2872-9. doi: 10.1093/ndt/gfr777. Epub 2012 Apr 23.
Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol. 2007 Sep;2(5):898-905. doi: 10.2215/CJN.04381206. Epub 2007 Aug 16.
EVOLVE Trial Investigators; Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.
Parfrey PS, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Dehmel B, Trotman ML, Modafferi DM, Goodman WG. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab. 2013 Dec;98(12):4834-44. doi: 10.1210/jc.2013-2975. Epub 2013 Oct 9.
Floege J, Tsirtsonis K, Iles J, Drueke TB, Chertow GM, Parfrey P. Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. Kidney Int. 2018 Jun;93(6):1475-1482. doi: 10.1016/j.kint.2017.12.014. Epub 2018 Mar 7.
Abdalla S, Montez-Rath ME, Parfrey PS, Chertow GM. The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial. Contemp Clin Trials. 2016 May;48:119-24. doi: 10.1016/j.cct.2016.04.001. Epub 2016 Apr 11.
Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drueke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.
Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. Clin J Am Soc Nephrol. 2015 May 7;10(5):800-7. doi: 10.2215/CJN.10221014. Epub 2015 Apr 17.
Kubo Y, Sterling LR, Parfrey PS, Gill K, Mahaffey KW, Gioni I, Trotman ML, Dehmel B, Chertow GM. Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial. Pharm Stat. 2015 May-Jun;14(3):242-51. doi: 10.1002/pst.1680. Epub 2015 Apr 6. Erratum In: Pharm Stat. 2015 Jul-Aug;14(4):368. doi: 10.1002/pst.1694.
Parfrey PS, Drueke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.
Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drueke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman ML, Abdalla S, Chertow GM, Herzog CA; EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. J Am Heart Assoc. 2014 Nov 17;3(6):e001363. doi: 10.1161/JAHA.114.001363. Erratum In: J Am Heart Assoc. 2015 Jan;4(1):e000570.

View record in ClinicalTrials.gov

18

Report

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

المؤلفون: Kyowa Kirin China Pharmaceutical Co., Ltd., Kyowa Kirin Korea Co., Ltd.

المصدر: A Phase 3, Randomized, Double-Blind, Intra-Subject Dose-Adjustment, Parallel-Group Study of KHK7580 and Cinacalcet Hydrochloride in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis

View record in ClinicalTrials.gov